Top 50 Biotech Angel Investors in May 2026
Top 50 Biotech Angel Investors in May 2026
| Investor | Biotech investments |
|---|---|
| Jonathan Milner | 33 |
| Milad Alucozai | 23 |
| Jeff Dean | 15 |
| Jude Gomila | 12 |
| Paul Buchheit | 12 |
| Jaffray Woodriff | 10 |
| Kingsley Advani | 9 |
| Farzad Nazem | 9 |
| Sam Altman | 9 |
| bumpkins profile | 9 |
| Jeff Hammerbacher | 9 |
| Jim Mellon | 8 |
| Sahin Boydas | 8 |
| Alice Zhang | 8 |
| Balaji Srinivasan | 8 |
| Wei Guo | 7 |
| Chris Gibson | 7 |
| Bradley Horowitz | 7 |
| Stefano Bernardi | 6 |
| Zach Weinberg | 6 |
| Evan Cheng | 6 |
| Cory Levy | 6 |
| Nadav Rosenberg | 6 |
| Fred Ehrsam | 5 |
| Daniel Curran | 5 |
| Bhavik Bajaj | 5 |
| Peter Thiel | 5 |
| Jan Hammer | 5 |
| Charlie Songhurst | 5 |
| Kevin Moore | 5 |
| Mark Cuban | 5 |
| Sake Bosch | 5 |
| Elad Gil | 5 |
| Anne Wojcicki | 5 |
| Brian Armstrong | 5 |
| Erik Peterson | 5 |
| Andrea Dusi | 4 |
| Annie Vereecken | 4 |
| Benjamin Kong | 4 |
| Brenton Saunders | 4 |
| Arda Kara | 4 |
| Bill Gates | 4 |
| Ling Wong | 4 |
| Bill Gates | 4 |
| Bernard Majoie | 4 |
| Rand Hindi | 4 |
| Avichal Garg | 4 |
| Darian Shirazi | 4 |
| Penny Schiffer | 4 |
| Nat Turner | 4 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Spain
Portfolio highlights
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Artificial Intelligence, Information Technology, Software
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Japan
Portfolio highlights
- RunSybil — RunSybil is an AI-driven offensive security platform that continuously evaluates applications and infrastructure for vulnerabilities. Leveraging cutting-edge AI techniques, it autonomously identifies and exploits real-world security flaws through sophisticated penetration testing. By automating hacker-like intuition, RunSybil delivers proactivedefense capabilities, empowering organizations to strengthen the security of modern applications.
- Meshcapade — Foundation models that teach AI to see, understand, and move.
- Supermemory — Supermemory offers a platform for organizing and retrieving saved knowledge through a combination of memory APIs, semantic search, and integrated tools. It enables users and developers to import content from documents, bookmarks, and external services, and then query that content using natural language. Supermemory supports workflows like building“second brain” systems, intelligent agents, and knowledge bases by connecting context across documents. It provides permission controls and integration with large language models to allow applications to maintain stateful, evolving memory. Supermemory also addresses use-cases in research, content writing, support systems, and enterprise knowledge management.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Software, Biotechnology, Information Technology
- Seed, Pre-Seed, Angel
- United States, United Kingdom, Canada
Portfolio highlights
- HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
- Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Software, E-Commerce, Health Care
- Seed, Series A, Angel
- United States, Canada, India
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- Character.ai — Chat with millions of AI Characters on the #1 AI chat app. Where will your next adventure take you?
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Angel Investor located in Charlottesville, VA
Show more...Investment focus
- Software, Biotechnology, Health Care
- Seed, Series A, Angel
- United States
Portfolio highlights
- Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
- Knit — Knit helps researchers run agency-quality quant + qual research at DIY costs, by taking the most time-intensive research tasks off their plate through Researcher-Driven AI.
- Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.
Show more...Investment focus
- FinTech, Biotechnology, Financial Services
- Seed, Pre-Seed, Series A
- United States, Singapore, United Kingdom
Portfolio highlights
- Orbit Fab — Orbit Fab is creating the future of on-orbit satellite refueling. We maximize your operational assets by enabling mission flexibility and freedom of action in space.
- Juvenescence — We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
- Volumetric — Advanced materials and 3D biofabrication.
Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.
Show more...Investment focus
- Health Care, Software, Analytics
- Seed, Series A, Series B
- United States, Canada
Portfolio highlights
- Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
- Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
- TigerGraph — TigerGraph is the leading AI-powered graph database. Uncover hidden relationships, run real-time analytics at scale, and power fraud detection, customer 360, and AI
Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.
Show more...Investment focus
- Software, Artificial Intelligence, Internet
- Seed, Series A, Series B
- United States, Canada, Ghana
Portfolio highlights
- NOYACK — NOYACK builds agentic AI technology for wealth management, starting with NOYACK.ai—the first AI agent for financial literacy - and Prophit.ai , the first opensource AI agent for portfolio optimizations of ALL asset classes. The fintech platform uses autonomous AI to deliver personalized financial guidance and construct tax-optimized portfolioscombining traditional accounts (IRAs, 401(k)s, HSAs) with private market investments in venture capital, fine art, and real estate for Millennials and Gen Z investors
- Boom Supersonic — Making the World Dramatically More Accessible
- Arcadia Medicine — Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Health Care, Biotechnology, Robotics
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Jeff Hammerbacher - Partner & Co-Founder @ Techammer
Show more...Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Series A, Angel
- United States, Germany
Portfolio highlights
- Vectara — Trusted AI Agents, Zero Compromises
- Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
- Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Biotechnology, Food and Beverage, Health Care
- Series A, Seed, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.
Show more...Investment focus
- Software, Financial Services, Information Technology
- Seed, Series A, Series B
- United States, Mexico, Norway
Portfolio highlights
- Labtree — Labtree is an AI-powered collaborative R&D platform that prevents experimental failures before labs waste their time and money.
- You.com — you.com is a search engine that helps users find what they're looking for by prioritizing real results. It aims to take on Google and other search engines dependent on advertising. It offers privacy controls to let users customize their browsing experience. It raises the bar on privacy, offering a zero trace incognito mode. It never tracksusers on the internet.You.com was developed by former Salesforce chief scientist Richard Socher.
- Harbinger — Founded by veterans of Canoo and Faraday Future, Harbinger is an automotive company that develops EV platforms optimized for medium-duty trucks and delivery vans.
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, United Kingdom
Portfolio highlights
- Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Series A, Pre-Seed
- United States, India, Singapore
Portfolio highlights
- fomo — Fomo is a cutting-edge fintech startup revolutionizing the financial landscape through innovative technology and strategic partnerships.
- Blitz Electric Mobility — Blitz provides electric vehicles and fleet management software to food and beverage delivery, courier, and logistics companies.
- Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.
Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.
Show more...Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Series A, Angel
- United States, China, Canada
Portfolio highlights
- tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
- Bungalow — Bungalow is a residential real estate platform that provides renters with a more convenient, flexible, and communal living solution. It utilizes existing housing supply by signing long-term leases with homeowners, and offers multi-bedroom homes in some of the most desirable neighborhoods in cities throughout the United States.Bungalow offersprivate bedrooms with handpicked housemates in beautifully furnished homes across seven major cities. Each home comes furnished and includes wifi, utilities, housekeeping, and monthly community events for members.Andrew Collins and Justin McCarty founded Bungalow in 2016. Its headquarters is in San Francisco in California.
- Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Seed
- United States, France, Switzerland
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- United States, United Kingdom, Germany
Portfolio highlights
- Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Opal — Making it better at capturing incredible low-light video. Even in dimly lit room, you’ll get a level of detail and color that wasn’t possible before.The Opal C1 comes with MicMesh™, an array of beamforming microphones that find and focus on the sound of your voice. And with intelligent noise cancellation, every ding, drop and dog bark is filteredout to get an audio experience that clearly speaks for itself.
- Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Software, Biotechnology, CleanTech
- Seed, Pre-Seed, Funding Round
- Italy, United Kingdom, France
Portfolio highlights
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
- Kresko Labs — Join the Quest for accessible wealth with Kresko, a synthetic asset protocol. Explore innovative possibilities now.
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more...Investment focus
- Software, Health Care, SaaS
- Seed, Series A, Pre-Seed
- United States, Israel, United Kingdom
Portfolio highlights
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
- Nym — Nym Health leverages advanced AI for medical coding, revolutionizing accuracy and speed within revenue cycle management. Discover the difference.
Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.
Show more...Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Pre-Seed, Funding Round
- United States, United Kingdom, Australia
Portfolio highlights
- Jarsy — Jarsy Inc offers a platform for global investment opportunities using stablecoins.
- PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
- Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.
Show more...Investment focus
- Artificial Intelligence, Software, Advertising
- Pre-Seed, Seed, Series A
- United States, Canada, United Kingdom
Portfolio highlights
- Hilt — Govern data movement in real time. Kernel-level telemetry and anomaly detection built for environments where traditional security tools fall short.
- Grata Health — Grata is an AI-enabled addiction treatment platform that pairs a virtual clinic (MAT, therapy, peer support) with software to triage, schedule, and support patients in under a minute. The patient app delivers continuous recovery touchpoints, and the EHR automates provider workflows and risk monitoring to improve retention and lower cost of care.
- Hidden Studios — Hidden Studios develops and advertises Fortnite Creative games, with 100M+ plays monthly. The company collaborated with prominent brands and creators, including Skydance, Snoop Dogg, and CaseOh, to deliver engaging gaming experiences. Hidden Studios maintains an active presence on YouTube, sharing content related to their Fortnite Creativeendeavors.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Biotechnology, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United Kingdom, France, Israel
Portfolio highlights
- Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Fred Ehrsam is the Co-Founder of Paradigm.
Show more...Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Series A, Series C
- United States, Canada, Israel
Portfolio highlights
- Swift Solar — Swift Solar is a US solar technology company building high-performance perovskite tandem products. Our mission is to unlock the full potential of solar energy.
- Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
- Arcadia Medicine — Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
Daniel Curran is the Founder and CEO at CustEx.com.
Show more...Investment focus
- E-Commerce, Software, Internet
- Seed, Series A, Series B
- United States, Canada, Brazil
Portfolio highlights
- RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
- Shred Video — Shred Video, a new startup launching out of Y Combinator, allows users to take footage from their iPhone, GoPro or drone and simply match it with a song from the user’s iTunes library. That’s all. Shred Video does the rest of the work.Taking into account the acceleration of the camera itself, Shred Video can pin-point the moments of action forsurfers, snowboarders, skaters and other acceleration-based sports to highlight all of the coolest clips in your footage. And beyond that, Shred Video matches those epic moments with the beat-drop of the song.
- GC Plus — Find Your Next Home Service Expert With Ease
Bhavik Bajaj
Show more...Investment focus
- Information Technology, Software, FinTech
- Pre-Seed, Seed, Angel
- United States, Switzerland, United Kingdom
Portfolio highlights
- Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
- ORA Technologies — E-Commerce, Super App
- THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING
Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.
Show more...Investment focus
- Software, FinTech, Financial Services
- Series A, Seed, Series B
- United States, Germany, Canada
Portfolio highlights
- STARK — EUROPEAN DEFENCE SOVEREIGNTY
- Plasma — Plasma is an operational setting that supports payments, real-world assets, and DeFi, with trustless settlement on Bitcoin.
- Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China, United States, France
Portfolio highlights
- Sofía — Improving the way millions of people take care of their health
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- United Kingdom, United States, Germany
Portfolio highlights
- Nexcade — Bringing intelligent automation to Freight Forwarding. Nexcade builds agents that meet forwarders where they work today- cutting through noise, accelerating descisions, and helping teams win more business.
- Forgent AI — Forgent uses AI agents to draft tender proposals, find opportunities and coordinate teams.
- Interface — Interface is an AI-native Document Management System for High Hazard Industries.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Software, Health Care, E-Commerce
- Seed, Pre-Seed, Angel
- United States, India, Canada
Portfolio highlights
- Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Augmend — Create documentation and an AI assistant from any video.
Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.
Show more...Investment focus
- Software, Artificial Intelligence, Blockchain
- Seed, Series A, Funding Round
- United States, United Kingdom, Canada
Portfolio highlights
- TransCrypts — We all have that file box where we throw all our important documents. Our goal at TransCrypts is to make that box digital and have all the documents secured through the blockchain. We currently offer industry leading privacy and security standards on our file storage and sharing platform and have solutions for individuals all the way to enterprises.
- Clipbook — Clipbook is an AI-powered research and analysis platform designed for public relations, communications, and public affairs teams. It monitors over 1 million sources including news, social media, policy documents, broadcasts, podcasts, and newsletters to deliver actionable media intelligence.
- The Renatural — Get rollercoaster proof wig security while protecting your hairline.
Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.
Show more...Investment focus
- Software, E-Commerce, Biotechnology
- Series A, Seed, Series B
- The Netherlands, France, Israel
Portfolio highlights
- LionVolt — LionVolt is a battery startup company that claims to develop the most efficient solid state lithium-ion battery.
- Recupere Metals — Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting.
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, United Kingdom, Israel
Portfolio highlights
- RunSybil — RunSybil is an AI-driven offensive security platform that continuously evaluates applications and infrastructure for vulnerabilities. Leveraging cutting-edge AI techniques, it autonomously identifies and exploits real-world security flaws through sophisticated penetration testing. By automating hacker-like intuition, RunSybil delivers proactivedefense capabilities, empowering organizations to strengthen the security of modern applications.
- Netic — Netic provides an AI-driven platform designed to automate and optimize customer engagement and operational workflows for essential service industries, including HVAC, plumbing, electrical, and appliance services. The platform autonomously handles inbound communications across various channels—such as calls, texts, and web chats—by bookingappointments and managing inquiries directly within existing CRM or field service management systems . Utilizing generative AI models, Netic's system assesses customer interactions to prioritize urgent requests, predict maintenance needs, and initiate targeted outreach campaigns based on factors like weather patterns and service history . This approach aims to enhance technician utilization and reduce missed revenue opportunities during periods of fluctuating demand . Additionally, Netic offers analytics tools that provide insights into customer interactions and operational performance, supporting data-informed decision-making .
- Decagon — Trusted by world-class companies, Decagon is the most advanced AI platform for customer support.
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Series B
- United States, United Kingdom, Canada
Portfolio highlights
- World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
- Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
- Endo Health — Reverse Your Diabetes With a Game
Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.
Show more...Investment focus
- Payments, Biotechnology, Financial Services
- Seed, Series A, Series B
- United States, Brazil
Portfolio highlights
- NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
- Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
- Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Software, Biotechnology, SaaS
- Seed, Equity Crowdfunding, Series A
- United States, Canada, Algeria
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.
Show more...Investment focus
- Biotechnology, Health Care, CleanTech
- Seed, Pre-Seed, Series A
- Italy, United States, United Kingdom
Portfolio highlights
- Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
- BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Annie Vereecken
Show more...Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Benjamin Kong is a Canadian investor backing early-stage transformative startups in Space, Biotech, Life Sciences, AI, Longevity, and Blockchain. He started investing in 2014 and has since funded over 50 startups and 3 VC funds. Recent early stage investments include Luminous Computing, Orbit Fab, Relativity Space, Swarm, TransAstra, RadianAerospace, Volumetric, OISIN, OncoSenX, Aegis BioDefense, Excision Biotherapeutics, MAIA Biotechnology, Ashvattha Therapeutics, ZenGo, Coinbase, Algorand, Oasis Labs, Arweave.
Show more...Investment focus
- Blockchain, Biotechnology, Cryptocurrency
- Seed, Pre-Seed, Funding Round
- United States, Israel, United Kingdom
Portfolio highlights
- Radian — Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
- Volumetric — Advanced materials and 3D biofabrication.
- Excision BioTherapeutics — Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Series B
- United States
Portfolio highlights
- Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
- Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
- Lipidio Pharmaceuticals — A Unique Approach to Treating Obesity Precision Targeting of the Skin Exploiting the skin as an endocrine organ Historically regarded as a protective barrier organ, the skin is now recognized as an active endocrine organ capable of synthesizing, and secreting diverse hormones and signaling
Arda Kara
Show more...Investment focus
- Health Care, Medical, Software
- Series A, Seed, Series B
- United States, Germany, Switzerland
Portfolio highlights
- Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
- Levels — Levels develops a health and wellness platform designed to monitor metabolic fitness. The platform tracks blood glucose in real-time, enabling users to optimize their diet and exercise. The company was founded in 2019 and is a remote-first company.
- Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.
Show more...Investment focus
- Energy, Biotechnology, Manufacturing
- Series C, Series A, Series B
- United States, Brazil, Canada
Portfolio highlights
- TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer.
- Inflection AI — Inflection AI is pioneering the future with human-centered, emotionally intelligent AI that transforms interactions from transactional to reltational, creating enduring value for individuals and enterprises alike.
- Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.
Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Colombia
Portfolio highlights
- Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
- Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
- Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.
Show more...Investment focus
- Biotechnology, Energy, Manufacturing
- Series A, Series B, Series C
- United States, Brazil, Canada
Portfolio highlights
- TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer. Learn about our projects, mission, and impact.
- Inflection AI — Inflection AI is a machine learning startup that engages in redefining human-computer interaction.
- Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Dr Rand Hindi is an entrepreneur and investor in 50+ deeptech and web3 companies. He is the CEO at Zama, a homomorphic encryption startup. Rand started coding at the age of 10, created a social network at 14, and started his PhD at 21. He then created Snips, the first private-by-design voice assistant, which was acquired by Sonos. He was electedan MIT TR35, a Forbes “30 under 30”, and was a lecturer at Sciences Po in Paris as well as a member of the French Digital Council.He holds a BSc in Computer Science and a PhD in Bioinformatics from University College London (UCL).
Show more...Investment focus
- Cryptocurrency, Software, Information Technology
- Seed, Pre-Seed, Funding Round
- France, United States, Germany
Portfolio highlights
- Twin — Twin Labs, offer an automated tool for repetitive operations, such as onboarding new staff to all internal systems.
- Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
- Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Software, Blockchain, Internet
- Seed, Series A, Funding Round
- United States, Canada, Mexico
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, Germany, Canada
Portfolio highlights
- Twenty (YC S23) — Building a better Salesforce, powered by the Open Source community.
- Twenty — Twenty builds the modern salesforce, powered by the open source community.
- Harmattan AI — Building the Future of Autonomous Warfare.
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Health Care, Medical, Finance
- Funding Round, Seed, Series A
- Switzerland, Germany, United Kingdom
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Health Care, Software, Medical
- Seed, Series A, Series B
- United States, China, Colombia
Portfolio highlights
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Memora Health — Meet patients where they are. Digitize your clinical workflows to modernize and simplify patient care.
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!